ZCI
CAI

Zevenbergen Capital Investments’s Caris Life Sciences CAI Stock Holding History

Zevenbergen Capital Investments’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Buy
802,083
+191,850
+31% +$3.43M 0.33% 54
2026
Q1 		$10.9M Buy
610,233
+67,048
+12% +$1.47M 0.31% 55
2025
Q4 		$14.7M Buy
+543,185
New +$15.3M 0.33% 50

Other funds holding CAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Zevenbergen Capital Investments's CAI Position: Q2 2026 in Review

Zevenbergen Capital Investments increased its Caris Life Sciences (CAI) stake by 31% in Q2 2026, buying an estimated $3.43M and bringing the position to 802,083 shares worth $14.3M. The position accounts for 0.33% of the portfolio, ranked #54.

Zevenbergen Capital Investments first reported a position in CAI in Q4 2025 and has held it in 3 quarters since. The position peaked at $14.7M in Q4 2025. 86 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Zevenbergen Capital Investments held 802,083 shares of Caris Life Sciences worth $14.3M as of Q2 2026.
  • Zevenbergen Capital Investments bought 191,850 Caris Life Sciences shares in Q2 2026, an estimated $3.43M.
  • Caris Life Sciences made up 0.33% of Zevenbergen Capital Investments's portfolio in Q2 2026, its #54 holding.
  • Zevenbergen Capital Investments first reported a position in Caris Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • Zevenbergen Capital Investments's Caris Life Sciences position peaked at $14.7M in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Zevenbergen Capital Investments's 13F filing for Q2 2026, filed 16 Jul 2026.